Lewis Rowland

Q: What Schools Are Affiliated With Lewis Rowland

Lewis Rowland is affiliated with the following schools: Yale University, Columbia University

Lewis Rowland's AcademicInfluence.com Rankings

Lewis Rowland

Medical

#914

World Rank

#1177

Historical Rank

#308

USA Rank

Neurology

#83

World Rank

#132

Historical Rank

#28

USA Rank

medical Degrees

Download Badge

Medical

Lewis Rowland's Degrees

Doctorate Medicine Columbia University

Why Is Lewis Rowland Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Lewis Phillip Rowland was an American neurologist. He served as president of the American Neurological Association and the American Academy of Neurology , and was editor of the journal Neurology from 1977 to 1987. He authored over 500 scientific articles, with a research emphasis on amyotrophic lateral sclerosis , and muscular dystrophy. He was chair of the neurology department at Columbia University for 25 years, where he established the H. Houston Merritt Clinical Research Center for Muscular Dystrophy and Related Diseases as well as the Eleanor and Lou Gehrig ALS Center.

(See a Problem?)

Lewis Rowland's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes: A distinctive clinical syndrome (1984) (1125)
Duchenne muscular dystrophy: Deficiency of dystrophin at the muscle cell surface (1988) (604)
Hashimoto encephalopathy: syndrome or myth? (2003) (540)
Inclusion body myositis and myopathies (1995) (482)
MELAS: Clinical features, biochemistry, and molecular genetics (1992) (481)
Deletions of mitochondrial DNA in Kearns‐Sayre syndrome (1988) (450)
MELAS: An original case and clinical criteria for diagnosis (1992) (339)
The natural history of primary lateral sclerosis (2006) (321)
Mitochondrial neurogastrointestinal encephalomyopathy: An autosomal recessive disorder due to thymidine phosphorylase mutations (2000) (318)
Merritt's textbook of neurology (1995) (312)
Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE) (1994) (311)
Lumping or splitting? “ophthalmoplegia‐plus” or kearns‐sayre syndrome? (1977) (310)
Plasma-cell dyscrasia and peripheral neuropathy with a monoclonal antibody to peripheral-nerve myelin. (1980) (302)
Clinical characteristics of a family with chromosome 17‐linked disinhibition‐dementia‐ parkinsonism‐amyotrophy complex (1994) (299)
Amyotrophic Lateral Sclerosis (1980) (270)
Merritt's Neurology (2001) (264)
Biochemistry of muscle membranes in Duchenne muscular dystrophy (1980) (258)
"Maximal" thymectomy for myasthenia gravis. Results. (1988) (257)
Guidelines for the Determination of Death (1982) (245)
Premorbid weight, body mass, and varsity athletics in ALS (2002) (244)
Myasthenic crisis (1997) (230)
Two novel pathogenic mitochondrial DNA mutations affecting organelle number and protein synthesis. Is the tRNA(Leu(UUR)) gene an etiologic hot spot? (1993) (229)
Pathogenesis of muscular dystrophies. (1976) (223)
The ALSFRSr predicts survival time in an ALS clinic population (2005) (217)
Prevalence of depressive disorders and change over time in late-stage ALS (2005) (214)
Prognosis of ocular myasthenia (1983) (210)
Monoclonal IgM with unique specificity to gangliosides GM1 and GD1b and to lacto‐N ‐tetraose associated with human motor neuron disease (1988) (199)
Quantitative objective markers for upper and lower motor neuron dysfunction in ALS (2007) (193)
Muscle phosphofructokinase deficiency. (1967) (185)
An observational study of cognitive impairment in amyotrophic lateral sclerosis. (2006) (153)
A disorder of muscle lipid metabolism and myoglobinuria. Absence of carnitine palmityl transferase. (1975) (149)
Dystrophinopathy in isolated cases of myopathy in females (1992) (144)
Complications of intravenous immune globulin treatment in neurologic disease (1996) (143)
Linkage of Miyoshi myopathy (distal autosomal recessive muscular dystrophy) locus to chromosome 2p12-14 (1995) (140)
How amyotrophic lateral sclerosis got its name: the clinical-pathologic genius of Jean-Martin Charcot. (2001) (135)
Physical and kinetic properties of human phosphofructokinase from skeletal muscle and erythrocytes. (1969) (132)
Emery‐dreifuss muscular dystrophy (1979) (131)
Surgical treatment of cervical spondylotic myelopathy (1992) (130)
Granulomatous angiitis of the brain. An inflammatory reaction of diverse etiology. (1988) (129)
Human motor neuron diseases. (1982) (129)
Lymphoma, motor neuron diseases, and amyotrophic lateral sclerosis (1991) (128)
Primary lateral sclerosis. A clinical diagnosis reemerges. (1988) (125)
Multifocal motor neuropathy with conduction block (1992) (117)
Controversies about the treatment of myasthenia gravis. (1980) (112)
Lymphoproliferative disorders and motor neuron disease (1997) (107)
Motor neuron diseases: comparison of single-voxel proton MR spectroscopy of the motor cortex with MR imaging of the brain. (1999) (107)
Neurolymphomatosis: a clinicopathologic syndrome re-emerges. (1992) (106)
A rational approach to total thymectomy in the treatment of myasthenia gravis. (1977) (104)
Familial aggregation of amyotrophic lateral sclerosis, dementia, and Parkinson's disease (1994) (104)
Drugs, coma, and myoglobinuria. (1972) (103)
X-linked dominant scapuloperoneal myopathy is due to a mutation in the gene encoding four-and-a-half-LIM protein 1. (2008) (103)
Motor neuron disease and plasma cell dyscrasia (1986) (102)
Structural and Molecular Basis of Skeletal Muscle Diseases (2003) (102)
Motor neuron disease and amyotrophic lateral sclerosis (1990) (102)
A prospective study of preferences and actual treatment choices in ALS (1999) (99)
Juvenile spinal muscular atrophy: A new hexosaminidase deficiency phenotype (1981) (96)
Adenyl cyclase in normal and pathologic human muscle. (1974) (93)
Diseases of Muscle: A Study in Pathology (1962) (92)
NEUROMUSCULAR DISORDERS ASSOCIATED WITH MALIGNANT NEOPLASTIC DISEASE. (1963) (92)
Clinical features that distinguish PLS, upper motor neuron–dominant ALS, and typical ALS (2009) (92)
Hyperkalemic periodic paralysis. (1967) (89)
Macroglobulinemia with peripheral neuropathy simulating motor neuron disease (1982) (89)
Diagnosis of amyotrophic lateral sclerosis (1998) (88)
Impact of spirituality and religiousness on outcomes in patients with ALS (2000) (86)
Molecular genetics, pseudogenetics, and clinical neurology (1983) (84)
Senataxin mutations and amyotrophic lateral sclerosis (2011) (84)
Progressive ophthalmoplegia, glycogen storage, and abnormal mitochondria. (1973) (84)
Inclusion body myositis mimicking motor neuron disease. (2001) (82)
Motor neuron diseases and amyotrophic lateral sclerosis (1984) (81)
Clinical syndromes associated with ragged red fibers. (1991) (79)
MYASTHENIA AS AN AUTOIMMUNE DISEASE: CLINICAL ASPECTS * (1966) (78)
Fatalities in Myasthenia Gravis (1956) (77)
Ten central themes in a decade of ALS research. (1991) (76)
McArdle disease: The mystery of reappearing phosphorylase activity in muscle culture—A fetal isoenzyme (1978) (76)
Study of 962 patients indicates progressive muscular atrophy is a form of ALS (2009) (75)
Wish to die in end-stage ALS (2005) (73)
Chromosome 12‐linked autosomal dominant scapuloperoneal muscular dystrophy (1996) (71)
Prospective study of palliative care in ALS: choice, timing, outcomes (1999) (69)
Association of myopathy with large‐scale mitochondrial dna duplications and deletions: Which is pathogenic? (1997) (69)
Molecular consequences of dominant Bethlem myopathy collagen VI mutations (2007) (69)
Reversible forms of motor neuron disease. Lead "neuritis". (1974) (67)
Normal pressure hydrocephalus and hypertensive cerebrovascular disease. (1974) (67)
Prion protein codon 129 genotype prevalence is altered in primary progressive aphasia (2005) (66)
MCARDLE'S DISEASE. HEREDITARY MYOPATHY DUE TO ABSENCE OF MUSCLE PHOSPHORYLASE. (1963) (64)
Bassen-Kornzweig Syndrome: Deficiency of Serum β-Lipoprotein: A Neuromuscular Disorder Resembling Friedreich's Ataxia, Associated with Steatorrhea, Acanthocytosis, Retinitis Pigmentosa, and a Disorder of Lipid Metabolism (1963) (63)
Predictors and course of elective long‐term mechanical ventilation: A prospective study of ALS patients (2006) (63)
How common is depression among ALS caregivers? A longitudinal study. (2009) (61)
Parkinsonism and motor neuron diseases: Twenty‐seven patients with diverse overlap syndromes (2010) (61)
Myology, 3rd ed (2005) (59)
On the function of the endocrine glands in myotonic muscular dystrophy. (1961) (58)
Sarcoplasmic reticulum in Duchenne muscular dystrophy. (1973) (57)
Möbius syndrome and facioscapulohumeral muscular dystrophy. (1971) (57)
Serum carnitine. An index of muscle destruction in man. (1973) (54)
Prostigmine‐Responsiveness and the Diagnosis of Myasthenia Gravis (1955) (54)
Neuropathy and anti‐MAG antibodies without detectable serum M‐protein (1984) (54)
High serum levels of creatine kinase: Asymptomatic prelude to distal myopathy (1987) (54)
Ammonia intoxication due to acongenital defect in urea synthesis (1964) (53)
Polyglucosan body disease (1991) (52)
Progressive ophthalmoplegia. Report of cases. (1968) (52)
Plasmapheresis in amyotrophic lateral sclerosis (1980) (52)
Objective tests for upper motor neuron involvement in amyotrophic lateral sclerosis (ALS) (2004) (50)
Transcranial magnetic stimulation in ALS (2009) (49)
Research Advances in Amyotrophic Lateral Sclerosis, 2009 to 2010 (2011) (48)
Clinical varieties of neuromuscular disease in debrancher deficiency. (1984) (48)
Muscular dystrophy in young girls (1970) (48)
Hyperkalemic periodic paralysis and cardiac arrhythmia (1972) (47)
Congenital hyperammonemia. Association with hyperglycinemia and decreased levels of carbamyl phosphate synthetase. (1970) (47)
Adenyl cyclase abnormality in Duchenne muscular dystrophy (1976) (47)
Amyotrophy in prion diseases. (2000) (47)
Clinical concepts of Duchenne muscular dystrophy. The impact of molecular genetics. (1988) (46)
MUSCULAR DYSTROPHY. FEATURES OF OCULAR MYOPATHY, DISTAL MYOPATHY, AND MYOTONIC DYSTROPHY. (1964) (46)
ULTRASTRUCTURAL STUDIES OF MUSCLE IN McARDLE'S DISEASE (1965) (45)
Myasthenia Gravis Appearing After the Removal of Thymoma (1957) (45)
The clinical diagnosis of McArdle's disease (1966) (45)
What's in a NAIM? Hashimoto encephalopathy, steroid-responsive encephalopathy associated with autoimmune thyroiditis, or nonvasculitic autoimmune meningoencephalitis? (2006) (45)
EFFECT OF PLASMAPHERESIS IN MYASTHENIA GRAVIS 1978‐1980 * (1981) (44)
Challenges and opportunities in clinical trials for spinal muscular atrophy (2005) (44)
Therapy for dermatomyositis and polymyositis. (1977) (44)
Contracture in McArdle's disease. Stability of adenosine triphosphate during contracture in phosphorylase-deficient human muscle. (1965) (43)
Current Neurology, Vol. (1979) (43)
Progressive muscular atrophy and other lower motor neuron syndromes of adults (2010) (43)
Amyotrophic lateral sclerosis: human challenge for neuroscience. (1995) (43)
Nystagmus in motor neuron disease: Clinicopathological study of two cases (1984) (42)
Adult-onset nemaline myopathy and monoclonal gammopathy. (2006) (42)
A benign motor neuron disorder: Delayed cramps and fasciculation after poliomyelitis or myelitis (1982) (42)
Diagnostic accuracy of clinical data, quantitative electromyography and histochemistry in neuromuscular disease. A study of 105 cases. (1974) (42)
Classification of neuromuscular disorders (1994) (41)
Cerebral hypoxia and its consequences. (1979) (38)
Randomized controlled phase II trial of glatiramer acetate in ALS (2006) (38)
Autopsy-proven amyotrophic lateral sclerosis, Waldenstrom's macroglobulinemia, and antibodies to sulfated glucuronic acid paragloboside (1995) (37)
Primary lateral sclerosis: disease, syndrome, both or neither? (1999) (37)
Potentially fata1 cardiac dysrhythmia and hyperkalemic periodic paralysis (1985) (37)
Motor neuron diseases and amyotrophic lateral sclerosis: research progress (1987) (37)
Incidence of amyotrophic lateral sclerosis among American Indians and Alaska natives. (2013) (36)
Riluzole for the treatment of amyotrophic lateral sclerosis--too soon to tell? (1994) (35)
Closing the tau loop: the missing tau mutation. (2015) (34)
The Testis in Myotonic Muscular Dystrophy: A Clinical and Pathologic Study with a Comparison with the Klinefelter Syndrome1 (1963) (34)
Amino acids of plasma and urine in diseases of muscle. (1971) (33)
A Monoclonal IgA in a Patient with Amyotrophic Lateral Sclerosis Reacts with Neurofilaments and Surface Antigen on Neuroblastoma Cells (1990) (32)
Pathogenesis of Human Muscular Dystrophies (1978) (32)
Amyotrophic lateral sclerosis: Theories and therapies (1994) (32)
Cell concentration and laminar thickness in the frontal cortex of psychotic patients; studies on cortex removed at operation (1949) (32)
Deletions of mitochondrial DNA in Kearns-Sayre syndrome (1998) (32)
Primary lateral sclerosis, hereditary spastic paraplegia, and mutations in the alsin gene: Historical background for the first International Conference (2005) (31)
Binding of enzymes of glycogen metabolism to glycogen in skeletal muscle. (1971) (31)
Partial dystrophin deficiency in monozygous twin carriers of the Duchenne gene discordant for clinical myopathy (1990) (31)
Assisted suicide and alternatives in amyotrophic lateral sclerosis. (1998) (30)
Treatment of cerebrotendinous xanthomatosis with chenodeoxycholic acid (1985) (30)
Myosin from normal and dystrophic human muscle. Immunochemical and electrophoretic studies. (1972) (30)
Cramps, spasms and muscle stiffness. (1985) (29)
Amyotrophic lateral sclerosis and lymphoma (1992) (29)
Neurological syndromes associated with congenital absence of the odontoid process. (1958) (29)
Homocystinuria: a report in two siblings. (1965) (28)
Diverse forms of motor neuron diseases. (1982) (28)
Incidence and predictors of PEG placement in ALS/MND (2001) (28)
Developing and Diseased Muscle. (1969) (28)
Myasthenic myopathy and thymoma (1973) (27)
Myasthenia gravis and epilepsy. (1958) (27)
Myasthenia gravis with a myeloma-type, gamma-G (IgG) immunoglobulin abnormality. (1969) (27)
Stroke, spasticity, and botulinum toxin. (2002) (26)
Amyotrophic lateral sclerosis with ragged-red fibers. (2008) (26)
What's in a name? Amyotrophic lateral sclerosis, motor neuron disease, and allelic heterogeneity (1998) (26)
ARE THE MUSCULAR DYSTROPHIES NEUROGENIC? * (1974) (25)
X-linked spinal muscular atrophy (Kennedy's syndrome). A kindred with hypobetalipoproteinemia. (1990) (25)
Lack of some muscle proteins in serum of patients with Duchenne dystrophy. (1968) (25)
Muscular dystrophies, polymyositis, and other myopathies. (1958) (24)
Chronic alveolar hypoventilation due to muscular dystrophy (1968) (24)
Transfer factor is ineffective in amyotrophic lateral sclerosis (1979) (24)
Motor neuron disease, lymphoproliferative disease, and bone marrow biopsy (1996) (23)
Fatalities in myasthenia gravis; a review of 35 cases, with 23 autopsies. (1953) (23)
Biochemistry and molecular genetics of human glycogenoses: An overview (1995) (23)
Sporadic amyotrophic lateral sclerosis and breast cancer: Hyaline conglomerate inclusions lead to identification of SOD1 mutation (2006) (23)
Fetal Echocardiographic Screening for Congenital Heart Disease: The Importance of the Four-Chamber View (1988) (22)
Relation between the coronal suture and cerebrum (1948) (22)
Magnetic Resonance Imaging of the Central Nervous System (1988) (22)
HTLV-1 and the Nervous System edited by Gustavo C. Roman, Jean-Claude Vernant and Mitsuhiro Osame, Alan R. Liss, 1989. $120.00 (664 pages) ISBN 0 8451 2755 1 (1989) (21)
Lowe's syndrome (1966) (21)
Thornton‐Griggs‐Moxley disease: Myotonic dystrophy type 2 (1994) (21)
Recent advances in amyotrophic lateral sclerosis research (2003) (21)
ALS Untangled No. 20: The Deanna Protocol (2013) (20)
Paraneoplastic primary lateral sclerosis and amyotrophic lateral sclerosis (1997) (20)
The Motor Endplate (1964) (19)
Myasthenia Gravis with Features Resembling Muscular Dystrophy (1956) (19)
Immunocytochemical study of nebulin in Duchenne muscular dystrophy (1988) (19)
Glycogen Metabolism of Human Diploid Fibroblast Cells in Culture. I. Studies of Cells from Patients with Glycogenosis Types II, III, and V (1973) (19)
Randomized control trials in ALS: lessons learned (2004) (18)
Maximum Thymectomy for Myasthenia Gravis (1987) (18)
The muddle of mycophenolate mofetil in myasthenia (2008) (18)
Six important themes in amyotrophic lateral sclerosis (ALS) research, 1999 (2000) (18)
Renal failure in McArdle's disease. (1972) (18)
Glycogen debrancher deficiency is reproduced in muscle culture (1981) (17)
Envoi (1986) (17)
Prostigmine‐Induced Muscle Weakness in Myasthenia Gravis Patients (1955) (17)
Myasthenia gravis, thymoma and cryptococcal meningitis. (1965) (17)
Myoglobin and muscular dystrophy. Electrophoretic and immunochemical study. (1968) (17)
Serum aldolase in muscular dystrophies, neuromuscular disorders, and wasting of skeletal muscle. (1958) (16)
Amyotrophic lateral sclerosis and autoimmunity. (1992) (16)
Kearns‐Sayre syndrome in twins (1988) (15)
General Discussion on Therapy in Myasthenia Gravis (1987) (15)
Multifocal motor neuropathy with conduction block: slow but not benign. (2006) (15)
Immunology of muscle disease. (1971) (15)
Is nebulin the defective gene product in Duchenne muscular dystrophy? (1987) (15)
Therapy in Myasthenia Gravis: Introduction (1987) (14)
Mitochondrial encephalomyopathies: lumping, splitting and melding (1994) (14)
HIV-related neuromuscular diseases: nemaline myopathy, amyotrophic lateral sclerosis and bibrachial amyotrophic diplegia (2011) (14)
Toxoplasmic polymyositis (1961) (14)
Looking for the cause of amyotrophic lateral sclerosis. (1984) (14)
Eosinophilic meningitis in a case of disseminated glioblastoma. (1981) (14)
Control of glycogen metabolism in human muscle. Evidence from glycogen storage diseases. (1970) (14)
A novel tRNAVal mitochondrial DNA mutation causing MELAS (2008) (14)
Neurology in Clinical Practice, 3rd ed (2000) (13)
Motor unit number estimation (MUNE) in diseases of the motor neuron: utility and comparative analysis in a multimodal biomarker study. (2009) (13)
Thyrotoxic periodic paralysis (1973) (13)
Seronegative myasthenia gravis (1988) (13)
'Ophthalmoplegia plus' or Kearns-Sayre syndrome? (1980) (13)
Bassen-Kornweig syndrome. Neuromuscular disorder resembling Friedreich's ataxia associated with retinitis pigmentosa, acanthocytosis, steatorrhea, and an abnormality of lipid metabolism. (1961) (13)
Oculopharyngeal muscular dystrophy, other ocular myopathies, and progressive external ophthalmoplegia (1997) (13)
Urinary excretion of carnitine in Duchenne muscular dystrophy. (1976) (12)
Current psychotherapeutic drugs (1996) (12)
Amyotrophic lateral sclerosis with paraproteins and autoantibodies. (1995) (12)
Neurology and Gulf War veterans. (2002) (12)
How Amyotrophic Lateral Sclerosis Got Its Name (2016) (11)
Clinical perspective: phenotypic expression in muscular dystrophy. (1985) (11)
Erroneous diagnosis corrected after 28 years. Not spinal muscular atrophy with ophthalmoplegia but minicore myopathy. (1996) (11)
Antibody to human myosin in man. (1969) (11)
McArdle disease: the mysterious appearance of phosphorylase activity in cells that ought to lack the genetic program. A fetal isoenzyme? (1977) (11)
ALSUntangled: Introducing The Table of Evidence (2015) (10)
Diagnostic biopsy of the motor nerve to the gracilis muscle. Technical note. (1996) (10)
IMMUNOSUPPRESSIVE DRUGS IN TREATMENT OF MYASTHENIA GRAVIS * (1971) (10)
Infiltrating lipoma: A cause of monomelic hypertrophy (1978) (10)
How common is depression among ALS caregivers? A longitudinal study (2009) (10)
Juvenile spinal muscular atrophy--a new hexosaminidase deficiency phenotype. (1981) (9)
Molecular Basis of Genetic Heterogeneity: Role of the Clinical Neurologist (1998) (9)
The Legacy of Tracy J. Putnam and H. Houston Merritt: Modern Neurology in the United States (2008) (9)
The first decade of molecular genetics in neurology: Changing clinical thought and practice (1992) (9)
Tarsal tunnel syndrome caused by hyperlipidemia. Reversal after plasmapheresis. (1983) (9)
Myasthenia gravis lacking response to cholinergic drugs (1973) (8)
ALSUntangled No. 16: Cannabis (2012) (8)
Paraoxonase genes and susceptibility to ALS (2009) (7)
Lymphoproliferative disorders and motor neuron disease (1998) (7)
Frontotemporal dementia, chromosome 17, and progranulin (2006) (7)
A link between ALS and short residence on Guam (2005) (7)
Diagnosis of Leigh's disease questioned defended (1974) (7)
Common Themes in the Pathogenesis of Neurodegeneration (2011) (7)
Ameliorating amyotrophic lateral sclerosis. (2010) (7)
Clinical characteristics of a family with chromosome 17-linked disinhibition-dementia-parkinsonism-amyotrophy complex. 1994. (2001) (7)
MCARDLE'S DISEASE: HEREDITARY MYOPATHY DUE TO ABSENCE OF MUSCLE PHOSPHORYLASE. (1963) (7)
Therapy of Myasthenia Gravis (ROSE) (1953) (6)
A novel tRNA<ce:sup loc=post>Val</ce:sup> mitochondrial DNA mutation causing MELAS (2008) (6)
An alert for motor neuron diseases and peripheral neuropathy: monoclonal paraproteinemia may be missed by routine electrophoresis. (1987) (6)
The Gene Masters: How a New Breed of Scientific Entrepreneurs Raced for the Biggest Prize in Biology (2003) (6)
Merritt's Neurology Handbook (2001) (6)
Amyotrophic lateral sclerosis and other motor neuron diseases. (1991) (6)
Andersen's syndrome? Or klein‐lisak‐andersen syndrome? (1994) (6)
ALSUntangled No. 26: Lunasin (2014) (6)
Endocrine Aspects of Myasthenia Gravis (1966) (6)
The 1990s—Decade of the Brain (1990) (6)
ALSUntangled 15: Coconut Oil (2012) (6)
Current Concepts of Myopathies. (1967) (5)
A new eponym (1994) (5)
Serum enzymes in the myopathies. (1960) (5)
ALS Untangled No. 17: “When ALS Is Lyme” (2012) (5)
Dystrophin: a triumph of reverse genetics and the end of the beginning. (1988) (5)
The long-acting anticholinesterase drugs in the management of myasthenia gravis. (1957) (5)
Suggestions to authors (1996) (5)
Amyotrophic Lateral Sclerosis (1977) (5)
A statement from the new Editor‐in‐Chief (1977) (5)
WALTER FREEMANʼS PSYCHOSURGERY AND BIOLOGICAL PSYCHIATRY: A CAUTIONARY TALE (2005) (4)
Kearns-Sayre syndrome or ophthalmoplegia-plus? To lump or to split? (1976) (4)
Merritt's Neurology 12/e (2009) (4)
Hyperkalemic periodic paralysis with cardiac arrhythmia. (1970) (4)
Amyotrophic lateral sclerosis, frontotemporal lobar dementia, and p62 (2012) (4)
ALS defeats gabapentin (2001) (4)
Presidential address: Thirty years of progress and problems in clinical neurology (1982) (4)
Molecular genetics in diseases of brain, nerve, and muscle (1989) (4)
Glycogen storage diseases of muscle problems in biochemical genetics. (1971) (4)
Treatment of Bell's palsy. (1972) (4)
Babinski and the diagnosis of amyotrophic lateral sclerosis (1993) (4)
Periodic paralysis: K levels during arrhythmia. (1972) (4)
ALSUntangled 38: L-serine (2017) (4)
Current concepts of the pathogenesis of myasthenia gavis. (1961) (3)
Neurolymphomatosis (1992) (3)
Peripheral neuropathy, plasma cell dyscrasia, and hot blood (1982) (3)
Neurological manifestations in sickle cell anemia. (1951) (3)
Cerebral Palsy and the Young Child. (1971) (3)
Controversies about amyotrophic lateral sclerosis. (1996) (3)
Muscle Contracture: Physiology and Clinical Classification (1999) (3)
H. HOUSTON MERRITT 1902–1979 (1979) (3)
A century and a half of modern neurology, a decade of the brain, and the millennium. (2000) (3)
Deletions of mitochondrial DNA in Kearns‐Sayre syndrome (1988) (3)
T.L. Bunina, Asao Hirano, and the post mortem cellular diagnosis of amyotrophic lateral sclerosis (2009) (3)
Ciba Foundation Symposium: Control of Glycogen Metabolism. (1965) (3)
Suggestions to authors (1988) (3)
Stiff muscles and bony tendons. (1970) (3)
[Muscle contractures. Essay on a physiopathological approach to clarify the nomenclature]. (1999) (3)
Deletions of mitochondrial DNA in Kearns-Sayre syndrome (2011) (3)
Mother with amyotrophic lateral sclerosis and daughter with Creutzfeldt-Jakob disease. (1999) (3)
Handbook of Clinical Neurology, vol 1: Disturbances of Nervous Function (1969) (2)
A NEW BOOK EVOKES MEMORIES OF THE EARLY DAYS OF THE NEURO-ICU (2005) (2)
Did Lou Gehrig Have Lou Gehrigʼs Disease (2010) (2)
Surgery for epilepsy. (1990) (2)
Proceedings of the 1987 IEEE particle accelerator conference: Accelerator engineering and technology (1988) (2)
Theodore L. Munsat, MD (1987) (2)
Heat-Related Muscle Cramps (1974) (2)
The quality of neurological care, 1997. (1997) (2)
Peripheral T-cell lymphoma emerging in a patient with aggressive polymyositis: molecular evidence for neoplastic transformation of an oligoclonal T-cell infiltrate (2013) (2)
Glycogen-storage diseases of muscle: genetic problems. (1983) (2)
Robert A. Fishman, MD (1924–2012) (2013) (2)
Research advances in amyotrophic lateral sclerosis (ALS): a personal view. (2005) (2)
SYMPOSIUM ON MUSCLE DISEASE. (1965) (2)
Sidney Carter, MD (1912–2005) (2005) (2)
Reconciling Language Differences in Describing States of Muscle Shortening: Muscle Contracture and Related Conditions (1999) (2)
Envoi: An Editor Leaves (1986) (2)
Silver syndrome (2008) (2)
Summing up: an action plan for ALS research (2004) (2)
ALSUntangled No. 37: Inosine* (2017) (2)
Multifocal motor neuropathy (1992) (2)
Genetics of Neurological and Psychiatric Disorders. Association for Research in Nervous and Mental Diseases, Volume 60 (1983) (1)
Frederick Tilney, 1876–1938 (1993) (1)
ALSUntangled No. 36: Accilion (2017) (1)
On the 60th anniversary of Neurology® (2011) (1)
Myoglobinuria, 1984 (1984) (1)
Handbook for Differential Diagnosis of Neurologic Signs and Symptoms (1979) (1)
Reply from the Authors (1996) (1)
George Karpati, MD (1934–2009) (2009) (1)
Book Review Decoding Darkness: The Search for the Genetic Causes of Alzheimer's Disease By Rudolph E. Tanzi and Ann B. Parson. 281 pp., illustrated. Cambridge, Mass., Perseus, 2000. $26. 0-7382-0195-2 (2001) (1)
Peer recommendations on how to improve clinical research, and Conference wrap-up (2013) (1)
Letter: Diagnosis of Leigh's disease questioned, defended. (1974) (1)
Book Review The Babinski Sign: A centenary By J. van Gijn. 176 pp. Utrecht, Heidelberglaan, the Netherlands, Universiteit Utrecht, 1996. $49.95. 90-9008908-X (1996) (1)
Introduction (1982) (1)
The Third Editor‐in‐Chief of Neurology (1986) (1)
Presidential address, 1981. (1981) (1)
In Memoriam: Robert A. Fishman, MD (1924-2012) (2013) (1)
Research progress in motor neuron diseases. (1988) (1)
Changing approaches to the management of seizures: pharmacologic considerations. Introduction. (1982) (1)
Medical Mimics of Neurodegenerative Diseases (2016) (1)
Amino acids of plasma and urine in muscular dystrophies. (1968) (1)
Dystrophia Myotonica and Related Disorders. (1964) (1)
[Searching for the cause of amyotrophic lateral sclerosis]. (1986) (1)
ALSUntangled No. 34: GM604. (2016) (1)
Book Review His Brother's Keeper: A Story from the Edge of Medicine By Jonathan Weiner. 356 pp. New York, Ecco, 2004. $26.95. 0-06-001007-X (2004) (1)
Raymond Adams: A Life of Mind and Muscle (2010) (1)
Suggestions to authors (1994) (1)
LYMPHOPROLIFERATIVE DISORDERS AND MOTOR NEURON DISEASE. AUTHORS' REPLY (1998) (1)
Relation of the trephine opening (Freeman-Watts lobotomy point) to the underlying cerebrum. (1948) (1)
WALTER FREEMAN'S PSYCHOSURGERY AND BIOLOGICAL PSYCHIATRY (2005) (1)
ALS: ON TRIAL FOR LIFE (2003) (0)
Progress in Neurological Research with Particular Reference to Motor Neuron Disease (1980) (0)
Risk Factors for Sporadic Amyotrophic Lateral Sclerosis (2007) (0)
Trophic functions of the neuron. IV. Clinical disorders of trophic function: muscular dystrophy? Are the muscular dystrophies neurogenic? (1974) (0)
Attachment to Life Scale (2015) (0)
Suggestions to authors (1990) (0)
Pediatric Neuromuscular Diseases (1980) (0)
DR. ROWLAND RESPONDS (2004) (0)
Gordon, P. H. et al. Randomized controlled phase II trial of glatiramer acetate in ALS. Neurology 66, 1117-1119 (2006) (0)
Merritt's neurology handbook for PDA (2004) (0)
Letters to the editor (1992) (0)
Reply from the Authors (1990) (0)
In Memoriam: Oliver Sacks, MD (July 9, 1933, to August 30, 2015). (2016) (0)
At jeopardy: the NIH as we know it. (2003) (0)
Who provides neurologic care? (1989) (0)
John Newsom-Davis, MD (1932-2007) (2007) (0)
Merritt’s Neurology, Thirteenth Edition (2016) (0)
Neurology Gets A Star Turn with Jane Fonda in New Broadway Play, ‘33 Variations’ (2009) (0)
Robert A. Fishman, MD (2013) (0)
A NOBEL LAUREATE OFFERS BOTH PERSONAL HISTORY AND A ‘SCIENTIFIC TOUR DE FORCE’ ON MEMORY (2006) (0)
Syndrome: Deficiency of Serum \g=b\-Lipoprotein (2016) (0)
ALSUntangled No. 35: Hyperbaric Oxygen Therapy* (2016) (0)
An Acknowledgement from the Editor (1977) (0)
A Bioethicist Ponders the ???Loftier Goals??? When Neuroscience is Applied to National Security Concerns (2007) (0)
Harry M. Zimmerman, 1901–1995 (1995) (0)
In Memoriam: Dewey K. Ziegler, MD (1920-2012) (2013) (0)
Bookshelf: The Story Behind an Immortal Cell Line: The Immortal Life of Henrietta Lacks. By Rebecca Skloot. Broadway Publishers (Paperback) 2011. 400 Pages. (2011) (0)
Life before MEDLINE: myasthenia gravis, muscular dystrophy, and myasthenic myopathy. (1989) (0)
Peripheral Neuropathy, Peter James Dyck, P.K. Thomas (Eds.). W. B. Saunders Company, Philadelphia (1993), 1,804, 3rd ed (in 2 vols) with illus, $335 (1993) (0)
Familial Neuromuscular Disease and Non-ketotic Glycinemia (1970) (0)
NINDS at 50 (2003) (0)
On Becoming the Former Chief Editor of Neurology Today (2009) (0)
WHY HAVENʼT WE BANNED BOXING (2006) (0)
Motor Neurone Disease (1978) (0)
Alfred Jaretzki III, MD. (2014) (0)
Tarsal Tunnel Syndrome Caused by Hyperlipidemia (2016) (0)
Scientific American Molecular Neurology edited by Joseph B. Martin (1999) (0)
Merritt, H. Houston (2014) (0)
ALS AND PARAPROTEINEMIA. AUTHOR'S REPLY (1991) (0)
ALS and paraproteinemia (1991) (0)
Mitochondrial DNA deletions and ophthalmoplegia (I: Reply) (1990) (0)
Suggestions for Authors (1989) (0)
The Mind's Eye (2011) (0)
Message from the Editor (1983) (0)
Dewey K. Ziegler, MD (1920–2012) (2013) (0)
Mind, Brain, Body, and Behavior: Foundations of Neuroscience and Behavioral Research at the National Institutes of Health (review) (2006) (0)
NerveCenter: Conversations in neurology: Lewis P. Rowland (2008) (0)
WELCOME TO NEUROLOGY TODAY (2001) (0)
Chronic Progressive External Ophthalmoplegia (1979) (0)
Diagnostic criteria in clinical trials. Discussion (1996) (0)
Muscle phosphofructokinase deficiency. (1967) (0)
GENERAL DISCUSSION (1979) (0)
IN62-TH-01 The causes of sporadic amyotropic lateral sclerosis (2009) (0)
Neuromuscular Diseases (1984) (0)
AN ACKNOWLEDGMENT (1984) (0)
Letter in reply to Brigell (2018) (0)
European ALS Consortium (EALSC): Second annual Research Workshop, a summary report (2005) (0)
Is Soccer Playing a Risk Factor for ALS (2005) (0)
Theodore L. Munsat, MD (1930–2013) (2014) (0)
Book Review Neurological Therapeutics: Principles and Practice Edited by John H. Noseworthy, with 14 others. 2874 pp. in two volumes, illustrated. London, Martin Dunitz, 2003. $450. 1-85317-623-0 (2003) (0)
Reply (1991) (0)
Suggestions to authors (1993) (0)
Muscular dystrophies. (1972) (0)
Book Review Parkinson's Disease: Diagnosis and Clinical Management Edited by Stewart A. Factor and William J. Weiner. 714 pp. New York, Demos Medical Publishing, 2002. $175. 1-888799-50-1 (2002) (0)
Ondine's Curse in Frontotemporal Dementia with Parkinsonism Linked to Chromosome 17 Caused by MAPT Variants (2021) (0)
Letter: Heat-related muscle cramps. (1974) (0)
Gene Product in Duchenne Muscular Dystrophy (DMD): Biochemical and Morphological Data Indicate that Nebulin is a Candidate Protein (1987) (0)
Concluding remarks. (2001) (0)
NEUROLOGY IN CUBA AND THE US EMBARGO (2003) (0)
AN ACKNOWLEDGMENT (1986) (0)
Reply (1985) (0)
ALS Center Reports (2000) (0)
Neuropathologist Kevin D. Barron, MD, Dies (2014) (0)
ALSUntangled No. 29: MitoQ (2015) (0)
Neuropsychiatry: a challenge for the Journal of Nervous and Mental Disease (JNMD). (2012) (0)
Ade T. Milhorat, MD (1899-1997) (1997) (0)
An Old Movie, A Newer Book Make Neurology Front and Center (2010) (0)
Brain Dysfunction in Metabolic Disorders (1976) (0)
Comprehensive neurology Edited by Roger N. Rosenberg, MD New York, Raven Press, 1991 936 pp, illustrated, $220 (1992) (0)
Amyotrophic lateral sclerosis: Humanchallenge forneuroscience (1995) (0)
Seronegative myasthenia gravis: the importance of clusters of acetylcholine receptors. (2012) (0)
Book Review From Neuroscience to Neurology: Neuroscience, Molecular Medicine, and the Therapeutic Transformation of Neurology Edited by Stephen Waxman. 513 pp., illustrated. San Diego, Calif., Elsevier Academic Press, 2005. $125. 0-12-738903-2 (2005) (0)
Complications of intravenous immune globulin treatment in neurologic disease (1997) (0)
Reply (1991) (0)
Comprar Merritt's Neurology 12/e | Dr. Lewis P. Rowland MD | 9780781791861 | Lippincott Williams & Wilkins (2009) (0)
Clinical research (1988) (0)
WHEN NO NEWS IS TERRIBLE NEWS: NEW YORK CITY, SEPTEMBER 11 (2001) (0)
DISCUSSION (1976) (0)
Myotonic Dystrophy (1980) (0)
Reply (1993) (0)
Doctors and Patients: An Interactive Partnership (2007) (0)
Two Insightful Accounts of the Pandemic of 1918: Encephalitis Lethargica (2011) (0)
At jeopardy: the NIH as we know it. (2003) (0)
Richard Lambert Masland, MD (1910–2003) (2004) (0)
Book Review The Interface of Neurology and Internal Medicine Edited by José Biller. 1021 pp., illustrated. Philadelphia, Lippincott Williams & Wilkins, 2008. $185. 978-0-7817-7906-7 (2008) (0)
Message from the editor‐in‐chief (1979) (0)
Suggestions to authors (1991) (0)
Diagnostic biopsy of the motor nerve to the gracilis muscle: Clinical pearl (1996) (0)
Lewis P. Rowland, MD (2017) (0)
The 2d Conference on the Clinical Delineation of Birth Defects. Part VII. Muscle. Dedication to G. Milton Shy (1919-1967). (1971) (0)
Amyotrophic Lateral Sclerosis: Foreword (1998) (0)
Message from the editor (1982) (0)
Myopathies, cardiomyopathies, and heart transplantation: a tribute to Giovanni Salviati (1999) (0)
Amyotrophic lateral sclerosis Edited by Hiroshi Mitsumoto, David A. Chad, and Erik P? Pioro Philadelphia, FA Davis, 1998 480 pp, illustrated, $140.00 (1998) (0)
Treatment of Neuromuscular Disorders (1966) (0)
NEUROLOGY TODAY EDITORS RESPOND (2004) (0)
NEED TO SHARE INFORMATION (2004) (0)
Spinal Muscular Atrophy. Infantile and Juvenile Type. (1979) (0)
Impact of molecular genetics on clinical neurology. (1988) (0)
AN ACKNOWLEDGMENT (1983) (0)
Ingrid D. Farreras, Caroline Hannaway, and Victoria A. Harden, eds. Mind, Brain, Body, and Behavior: Foundations of Neuroscience and Behavioral Research at the National Institutes of Health (2006) (0)
Muscular Dystrophy in Man and Animals. (1963) (0)
Comprar Merritt's Neurology, 13ª Ed. | Elan D. Louis | 9781451193367 | Lippincott Williams & Wilkins (2015) (0)
Letters to the editor (0)
Reliability of the oral certifying examination for neurologists (1980) (0)
VIIth International Congress on Neuromuscular Diseases 16–22 September 1990, Munich, F.R.G. (1991) (0)
Biochemistry of Muscle Contraction. (1965) (0)
‘Brain: The Inside Story’ — An Exhibition at the American Museum of Natural History — Is Worth the Visit (2011) (0)
Book Reviews (2006) (0)

This paper list is powered by the following services:

Other Resources About Lewis Rowland

en.wikipedia.org

What Schools Are Affiliated With Lewis Rowland?

Lewis Rowland is affiliated with the following schools:

Lewis Rowland's Academic­Influence.com Rankings